Pelthos Therapeutics, Inc. (PTHS)
9.48
+0.18
(+1.94%)
USD |
NYAM |
Nov 06, 10:06
Pelthos Therapeutics Market Cap : 35.25M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 34.58M |
| November 04, 2026 | 37.74M |
| November 03, 2026 | 40.09M |
| November 02, 2026 | 42.84M |
| October 30, 2026 | 34.95M |
| October 29, 2026 | 61.51M |
| October 28, 2026 | 58.53M |
| October 27, 2026 | 53.92M |
| October 26, 2026 | 56.52M |
| October 23, 2026 | 63.22M |
| October 22, 2026 | 72.85M |
| October 21, 2026 | 69.54M |
| October 20, 2026 | 76.23M |
| October 19, 2026 | 75.34M |
| October 16, 2026 | 74.93M |
| October 15, 2026 | 75.34M |
| October 14, 2026 | 75.30M |
| October 13, 2026 | 75.45M |
| October 12, 2026 | 72.59M |
| October 09, 2026 | 76.23M |
| October 08, 2026 | 76.23M |
| October 07, 2026 | 78.05M |
| October 06, 2026 | 79.88M |
| October 05, 2026 | 76.23M |
| October 02, 2026 | 76.60M |
| Date | Value |
|---|---|
| October 01, 2026 | 75.67M |
| September 30, 2026 | 78.13M |
| September 29, 2026 | 77.79M |
| September 28, 2026 | 79.02M |
| September 25, 2026 | 82.52M |
| September 24, 2026 | 83.30M |
| September 23, 2026 | 87.46M |
| September 22, 2026 | 86.42M |
| September 21, 2026 | 86.09M |
| September 18, 2026 | 84.23M |
| September 17, 2026 | 83.22M |
| September 16, 2026 | 72.22M |
| September 15, 2026 | 75.56M |
| September 14, 2026 | 81.59M |
| September 11, 2026 | 81.44M |
| September 10, 2026 | 83.41M |
| September 09, 2026 | 87.09M |
| September 08, 2026 | 91.29M |
| September 04, 2026 | 90.55M |
| September 03, 2026 | 90.59M |
| September 02, 2026 | 93.08M |
| September 01, 2026 | 92.30M |
| August 31, 2026 | 89.54M |
| August 28, 2026 | 91.96M |
| August 27, 2026 | 92.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Travere Therapeutics, Inc. | 4.764B |
| ACADIA Pharmaceuticals, Inc. | 3.601B |
| Alnylam Pharmaceuticals, Inc. | 21.09B |
| Anika Therapeutics, Inc. | 224.83M |
| Savara, Inc. | 934.57M |
Market Cap Related Metrics
| PS Ratio | 0.7152 |
| PEG Ratio | -0.0019 |
| Price | 9.48 |
| Earnings Yield | -278.0% |
| PEGY Ratio | -0.0019 |